Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07167940 · ClinicalTrials.gov registry record · Phase 3
Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days
A Phase 3 study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- Phase 3
- Development phase
- 90
- Enrollment target
NCT07167940: Clinical Trial Phase 3 study, sponsored by VA Office of Research and Development.
NCT07167940 is a Phase 3 study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07167940, a Phase 3 study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 90 participants
- Enrollment target
Study Summary
Veterans with posttraumatic stress disorder (PTSD) need more effective treatments. Existing options can have limited adherence and can be very time-consuming. As such, alternative interventions are needed. Transcranial magnetic stimulation (TMS) has been FDA-cleared for depression since 2008 and has recently been cleared to treat smoking cessation and obsessive-compulsive disorder. It has demonstrated promise for reducing PTSD symptom severity but standard TMS has a significant time requirement. This study will compare an accelerated 5-day form of TMS versus sham for PTSD, characterizing efficacy and durability. This project will provide important information that can be implemented in the near term for Veterans with PTSD.
Interventions
- DEVICE Transcranial magnetic stimulation
- DEVICE Sham transcranial magnetic stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2030-07-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07167940
The ClinicalTrials.gov registry entry for NCT07167940 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial magnetic stimulation is the first listed.
NCT07167940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07167940 about?
NCT07167940 is a clinical study titled "Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days". Veterans with posttraumatic stress disorder (PTSD) need more effective treatments. Existing options can have limited adherence and can be very time-consuming. As such, alternative interventions are needed. Transcranial magnetic stimulation (TMS) has been FDA-cleared for depression since 2008 and has...
What is the current status of trial NCT07167940?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 90 participants. The study started on 2026-07-01. Estimated completion is 2030-07-01.
What interventions are being tested in trial NCT07167940?
The interventions under investigation include: Transcranial magnetic stimulation (DEVICE), Sham transcranial magnetic stimulation (DEVICE).
Who is sponsoring clinical trial NCT07167940?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.